Compare ECOR & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECOR | GRF |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 41.0M |
| IPO Year | 2018 | N/A |
| Metric | ECOR | GRF |
|---|---|---|
| Price | $7.16 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 52.1K | 1.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | ★ $32,032,000.00 | N/A |
| Revenue This Year | $33.60 | N/A |
| Revenue Next Year | $30.40 | N/A |
| P/E Ratio | ★ N/A | $8.91 |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.16 | $9.50 |
| 52 Week High | $8.30 | $11.85 |
| Indicator | ECOR | GRF |
|---|---|---|
| Relative Strength Index (RSI) | 63.43 | 46.30 |
| Support Level | $4.55 | $9.96 |
| Resistance Level | $7.50 | $10.63 |
| Average True Range (ATR) | 0.48 | 0.16 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 90.60 | 46.68 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.